Building a healthier future for Kazakhstan
Abdi Ibrahim Global Pharm manufactures high-quality medicines that meet international standards — because everyone deserves access to trusted healthcare.
Abdi İbrahim’s first production site abroad and one of the most modern pharmaceutical plants in Kazakhstan. Modern production technologies, scientific excellence and a people-centred approach.
Key therapeutic areas
The AIGP portfolio includes around 100 products: antibacterials and antivirals, cardiology, dermatology, endocrinology and metabolism, gastroenterology, neurology, NSAIDs and muscle relaxants, respiratory products, and vitamins and minerals.
Our GMP-compliant plant is one of the most modern pharmaceutical production facilities in Kazakhstan. We invest in state-of-the-art laboratories and research equipment and are a trusted partner in contract manufacturing.
Our medicines
Tanflex SEPT
Enzimax Forte
Lifta
Tanflex
Tanflex Forte
Tanflex Plus
Muconex
Vision and values
We are committed to building a healthier future for the people of Kazakhstan and neighbouring countries.
Part of the international Abdi İbrahim group
A history dating back to 1912, leadership of the Turkish pharmaceutical market since 2003 and modern production facilities in Türkiye, Kazakhstan and Algeria.
Healing the Future
Abdi İbrahim’s sustainability strategy focuses on three areas.
Future of the ecosystem
Environmental sustainability across the value chain, with a target of carbon neutrality by 2030.
Future of people
Caring for employees and society; diversity, equality and inclusion.
Future of business
Industry leadership, responsibility and an innovative approach.
Partnership opportunities
GMP compliance and investment in state-of-the-art laboratories and research equipment make AIGP a trusted partner in contract manufacturing.
